Sangani Hospital Ltd.

Sangani Hospital Ltd.

NNSE:SANGANI
59.70
INR
0.00
(0.00%)
535.92MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
3.22
3.61
7.46
11.37
12.63
15.38
77.64
- -
Basic EPS, GAAP
0.17
0.57
1.59
1.11
2.17
1.88
3.63
- -
Free Cash Flow per Basic Share
0.9
0.39
0.43
1.87
2.71
1.75
3.61
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.33
1.23
6.24
13.06
24.31
26.19
29.75
29.75
Tangible Book Value per Share
1.33
1.23
6.24
13.06
24.31
26.19
23.3
23.3
Basic Weighted Avg Shares
14
14
14
14
12
14
14
14
Sales/Revenue/Turnover
44
50
103
157
157
212
1,070
- -
Operating Margin (%)
7.59
22.62
28.99
12.86
18
8.79
6.67
- -
Depreciation Expense
1
1
1
10
3
6
10
- -
Net Income, GAAP
2
8
22
15
27
26
50
- -
Effective Tax Rate (%)
25.16
25.15
25.5
25.15
25.76
25.07
27.94
- -
Profit Margin (%)
5.14
15.88
21.34
9.78
17.2
12.24
4.68
- -
Working Capital
13
11
72
63
208
208
204
204
LT Debt
3
3
4
1
1
1
13
13
Total Equity
18
17
86
180
335
361
506
506
Return on Invested Capital (%)
- -
39.87
39.66
10.68
8.05
3.97
11.19
- -
Return on Capital (%)
- -
40.19
40.36
11.3
10.52
7.43
9.95
- -
Return on Common Equity (%)
- -
44.84
42.64
11.52
10.48
7.45
12.98
- -

Capital Structure

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
- -
- -
22
LT Borrowings
1
12
13
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
984
992
536

Working Capital

INR

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
233
228
813
Cash, Cash Equivalents & STI
182
77
158
Accounts Receivable, Net
29
133
615
Inventories
11
11
14
Total Current Liabilities
24
116
609
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
22
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
130.55%
40.01%
Free Cash Flow
- -
91.1%
106.63%
Net Income, GAAP
- -
62.57%
92.97%
Sales/Revenue/Turnover
- -
119.84%
404.87%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
157
2025
- -
- -
212
2026
- -
- -
1,070

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.17
2025
- -
- -
1.88
2026
- -
- -
3.63

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Ajaykumar Natvarlal Sangani
Full Time Employees
162
Sector
Health services
Industry
Hospital/Nursing management
Address
Sainath Society, Opp. S.T., KSD T, Village Keshod, Taluka Keshod Junagadh GU India 362220
IPO Date
Aug 17, 2023
Business
Sangani Hospitals Limited (NSE: SANGANI) operates multi-specialty hospitals, pathology laboratories, and pharmacy stores primarily in the Keshod and Veraval regions of Gujarat, India. The company offers a comprehensive range of primary, secondary, and tertiary healthcare services, including specialty and super specialty care in cardiac sciences, neurosciences, orthopedics, renal sciences, mother and childcare; general medicine, urology surgery, laparoscopic surgery, ENT head and neck surgery, gynecology, infertility clinic, dialysis, endoscopy, audiology, vertigo clinic, radiology (X-ray, sonography, CT scan), and other support services such as MD-ICU, ICCU, echo, TMT, and EECP. It operates two key facilities: Sangani Hospital, a 36-bed multi-specialty hospital in Keshod, Junagadh district, offering primary to tertiary care and preparing for NABH accreditation; and Sangani Super Speciality Hospital, a 32-bed NABH entry-level certified facility in Veraval, Gir Somnath district, with a focus on tertiary care. Additional operations include two pathology laboratories and two medical stores, with free dialysis services provided to thousands of patients annually under government schemes like PM-JAY and Mukhyamantri Amrutum Yojana. Incorporated on November 11, 2021, in Ahmedabad, Gujarat, under the Companies Act, 2013, the company is promoted by Dr. Ajaykumar Natwarlal Sangani and Dr. Rajeshkumar Natwarlal Sangani, with headquarters effectively based in Keshod, Gujarat (Sainath Society, Opp. S.T., KSD Taluka). The hospitals comply with ISO 9001:2015 quality management standards across various departments and participate in government schemes for free surgeries. Sangani Hospitals targets underserved rural and semi-urban populations in Gujarat, serving patients from over 50 adjacent villages through strategically located facilities near transport hubs. In recent developments, the company listed its equity shares on the National Stock Exchange of India on August 17, 2023, enabling public funding for expansions. It launched an ultra-modern dialysis center in Keshod in 2023 and received the News 18 Gujarati award for Most Trusted and Exemplary Hospital in Keshod. On March 7, 2024, Sangani Hospitals entered a Memorandum of Understanding to acquire Aashirvad Hospital, followed by a share purchase agreement on March 28, 2025, to acquire a 55% stake (12,223 equity shares) in Sadbhavna Hospital and Medical Research Centre Pvt. Ltd. for ₹18.81 crore in cash, aiming for strategic expansion and alignment in healthcare services, with completion expected within one year. Earlier, in December 2021, it acquired running businesses from related proprietorships and partnerships, including Sangani Laboratories, Ankur Laboratory, Ankur Medical Store, Ankur Medicines, and Sangani Super Speciality Hospital via business transfer agreements, and took 95% ownership in Ankur Distributors. These moves support bed capacity growth, new service diversification, and infrastructure upgrades at its Gujarat facilities.